Mefenamic Acid
NDC Package 0574-0195-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Mefenamic Acid is used for the short-term treatment of mild to moderate pain from various conditions. Marketed by Paddock Laboratories, Llc, this product is identified by NDC 0574-0195 and is authorized under FDA application ANDA090562.

Identification & Billing

NDC Package Code
0574-0195-01
Package Description
100 CAPSULE in 1 BOTTLE
Product Code
0574-0195
11-Digit Billing Format
00574019501
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA

Clinical Specifications

Proprietary Name
Mefenamic Acid
Dosage Form
-
Usage Information
Mefenamic acid is used for the short-term treatment of mild to moderate pain from various conditions. It is also used to decrease pain and blood loss from menstrual periods. Mefenamic acid is known as a nonsteroidal anti-inflammatory drug (NSAID).

Regulatory & Marketing

Labeler Name
Paddock Laboratories, Llc
FDA Application #
ANDA090562
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
11-19-2010
End Marketing Date
03-01-2016
Listing Expiration
03-01-2016
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0574-0195). Click a package code to view its specific billing and regulatory data.

0574-0195-30
30 CAPSULE in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0574-0195-01 identifies a specific commercial package of 100 capsule in 1 bottle of Mefenamic Acid, labeled by Paddock Laboratories, Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Paddock Laboratories, Llc on November 19, 2010. The current certification is valid through March 01, 2016.

What are the primary indications for this medication?

Mefenamic acid is used for the short-term treatment of mild to moderate pain from various conditions. It is also used to decrease pain and blood loss from menstrual periods. Mefenamic acid is known as a nonsteroidal anti-inflammatory drug (NSAID).

How is this Paddock Laboratories, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00574019501. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0574-0195-01
11-Digit CMS (5-4-2)
00574-0195-01

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.